Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Maternal alloimmunization against the rare platelet‐specific antigen HPA‐9b (Max<sup>a</sup>) is an important cause of neonatal alloimmune thrombocytopenia

10 Aug 2005

Abstract excerpt

BACKGROUND: Neonatal alloimmune thrombocytopenia (NATP) is an important cause of morbidity and mortality in the newborn. Optimal management of subsequent pregnancies requires knowledge of the alloantigen that caused maternal immunization, but this is possible only in a minority of cases. This study investigated whether this can be explained in part by maternal immunization against the "rare" alloantigen HPA-9b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood groups and transfusion
Share to Cell Adhesion Molecules Research
Share to Platelet Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16131382
DOI: 10.1111/j.1537-2995.2005.00561.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Maternal alloimmunization against the rare platelet‐specific antigen HPA‐9b (Max<sup>a</sup>) is an important cause of neonatal alloimmune thrombocytopeniaPMID 16131382Read ↗

Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens.Semantic proximity Read ↗

Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.Semantic proximity Read ↗

Low-frequency human platelet antigens as triggers for neonatal alloimmune thrombocytopenia.Semantic proximity Read ↗

Max(a), a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia.Semantic proximity Read ↗

A V740L mutation in glycoprotein IIb defines a novel epitope (War) associated with fetomaternal alloimmune thrombocytopenia.Semantic proximity Read ↗

New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopenia.Semantic proximity Read ↗

New K103 β3 allele identified in a context of severe neonatal thrombocytopenia.Semantic proximity Read ↗

Fetal and neonatal alloimmune thrombocytopenia: Current pathophysiological insights and perspectives for future diagnostics and treatmentSemantic proximity Read ↗

HPA-13bw neonatal alloimmune thrombocytopenia and low frequency alloantigens: case report and review of the literature.Semantic proximity Read ↗

Fetal-neonatal alloimmune thrombocytopenia and unexpected Glanzmann thrombasthenia carrier: report of two cases.Semantic proximity Read ↗

HLA‐DRB3*01:01 is a predictor of immunization against human platelet antigen‐1a but not of the severity of fetal and neonatal alloimmune thrombocytopeniaSemantic proximity Read ↗

Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.